Clinical Study
Predictors of Developing Hepatocellular Carcinoma in Treated HCV-Carriers in Morocco according to University Hospital Experience
Table 1
General features of HCV-treated patients with developed HCC.
|
Gender
| | Male | 08 | Female | 12 |
Mean age | 61 years old. |
Mean time of HCC occurrence | 5 ± 2 years |
HCV genotypes | | HCV-1 | 53% | HCV-2 | 47% |
Fibrosis (METAVIR score) | | Severe | 94.6% | Reduced | 5.4% | Response to antiviral treatment | | Sustained virological responders | 06 | Non-SVR patients | 14 |
|
|